Abstract
Aim: Radiofrequency thermal ablation (RFA) has shown promise as a technique for treating solid tumors. This method has been suggested as an alternative to surgery in patients with adrenocortical carcinoma (ACC).
Materials and Methods: We reviewed the literature, and report the case of a patient with stage 4 ACC who received intraoperative and percutaneous RFA of two liver metastasis according to a standard ablation protocol.
Results: Post-interventional imaging in our patient demonstrated that after both interventions, a stellar-like structure of vital tumor tissue had remained within the coagulation necrosis. This was the starting point of a fast and progressive tumor recurrence. We suspect heat-sink effects of blood vessels in the highly vascularized metastasis to cause the tumor recurrence. In literature, there are only a few reports of RFA in ACC patients. In addition, there is no large randomized trial investigating the efficacy of RFA against surgery in those patients.
Conclusions: Presently, RFA in ACC should be restricted to patients in whom surgery is contraindicated. It is necessary that strongly vascularized ACC metastases deserve a modified ablation protocol due to perfusion related cooling effects and to increase the efficacy of RFA.
Key words
hepatic metastases - adrenocortical cancer - radiofrequency thermal ablation - heat sink effects - liver
References
1
Abiven G, Coste J, Groussin L. et al .
Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.
J Clin Endocrinol Metab.
2006;
91
2650-2655
2
Abraham J, Fojo T, Wood BJ.
Radiofrequency ablation of metastatic lesions in adrenocortical cancer.
Ann Intern Med.
2000;
133
312-313
3
Allolio B, Fassnacht M.
Clinical review: Adrenocortical carcinoma: clinical update.
J Clin Endocrinol Metab.
2006;
91
2027-2037
4
Brown DB.
Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation.
J Vasc Interv Radiol.
2005;
16
597-613
5
Chok KS, Ng KC, Lam CM. et al .
Selective portal vein clamping for radiofrequency ablation of hepatocellular carcinoma with portal vein invasion.
J Gastrointest Surg.
2005;
9
489-493
6
Curley SA, Izzo F, Delrio P. et al .
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.
Ann Surg.
1999;
230
1-8
7
Beare T de, Bessoud B, Dromain C. et al .
Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.
AJR Am J Roentgenol.
2002;
178
53-59
8
Beare T de, Palussiere J, Auperin A. et al .
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
Radiology.
2006;
240
587-596
9
Gillams AR, Lees WR.
Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer.
Dis Colon Rectum.
2000;
43
656-661
10
Goetz MP, Callstrom MR, Charboneau JW. et al .
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.
J Clin Oncol.
2004;
22
300-306
11
Hori T, Nagata K, Hasuike S. et al .
Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
J Gastroenterol.
2003;
38
977-981
12
Komorizono Y, Oketani M, Sako K. et al .
Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Cancer.
2003;
97
1253-1262
13
Koschker AC, Fassnacht M, Hahner S. et al .
Adrenocortical carcinoma – improving patient care by establishing new structures.
Exp Clin Endocrinol Diabetes.
2006;
114
45-51
14
Lin SM, Lin CJ, Lin CC. et al .
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma<or=4 cm.
Gastroenterology.
2004;
127
1714-1723
15
Livraghi T, Goldberg SN, Lazzaroni S. et al .
Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.
Radiology.
2000;
214
761-768
16
Livraghi T, Goldberg SN, Lazzaroni S. et al .
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.
Radiology.
1999;
210
655-661
17
Lu DS, Raman SS, Limanond P. et al .
Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
J Vasc Interv Radiol.
2003;
14
1267-1274
18
Rhim H, Dodd GD, Chintapalli KN. et al .
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.
Radiographics.
2004;
24
41-52
19
Schteingart DE, Doherty GM, Gauger PG. et al .
Management of patients with adrenal cancer: recommendations of an international consensus conference.
Endocr Relat Cancer.
2005;
12
667-680
20
Solbiati L, Livraghi T, Goldberg SN. et al .
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.
Radiology.
2001;
221
159-166
21
Wajchenberg BL, Bergaria Pereira MA, Medonca BB. et al .
Adrenocortical carcinoma: clinical and laboratory observations.
Cancer.
2000;
88
711-736
22
Wood BJ, Abraham J, Hvizda JL. et al .
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases.
Cancer.
2003;
97
554-560
23
Yamasaki T, Kurokawa F, Shirahashi H. et al .
Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
Cancer.
2002;
95
2353-2360
1 Both authors contributed equally to this work.
Correspondence
M. QuinklerMD
Internal Medicine
Center for Gastroenterology
Hepatology and Endocrinology Charité Campus Mitte
Charité University Medicine Berlin
Charitéplatz 1
10117 Berlin
Germany
Telefon: +49/30/450 51 41 52
Fax: +49/30/450 51 49 52
eMail: marcus.quinkler@charite.de